19054-Breast Cancer-NA-617

Breast Cancer

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Address

5400 Kell West Blvd
Wichita Falls, TX 76310
P: (940) 691-8271

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.